Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,700.00
Ask: 1,770.00
Change: 0.00 (0.00%)
Spread: 70.00 (4.118%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Italian shares jump on Draghi hope; GSK weighs on FTSE 100

Wed, 03rd Feb 2021 09:18

* Milan stocks rise on hopes of Draghi becoming next PM

* Daimler jumps on plan to spin-off truck business

* GSK slides; warns of bigger than expected fall in 2021
earnings
(Updates to close)

By Shreyashi Sanyal and Susan Mathew

Feb 3 (Reuters) - Italian shares posted their best session
in four weeks on Wednesday after former European Central Bank
chief Mario Draghi accepted the task of forming a new
government, while a surge in German carmaker Daimler lifted an
index of broader European shares.

Milan's FTSE MIB index closed up 2.1%, while
Italy's 10-year bond yield tumbled.

Draghi said he was confident of securing sufficient backing
in parliament after President Sergio Mattarella sought his help
after hearing that efforts to salvage the collapsed coalition of
Prime Minister Giuseppe Conte had failed.

"It may not all be plain sailing and some uncertainties and
negotiations remain. But... markets like the news of well-known
central bankers at the helm of government," said Maria Paola
Toschi, global market strategist at J.P. Morgan Asset
Management.

"For the economy, avoiding lengthy further attempts to form
a government should mean that critical near-term issues can be
addressed."

Italy has been hit by the COVID-19 pandemic and economic
crises against the backdrop of political uncertainty battering
the country.

On the pan-European STOXX 600 index Daimler
was the top boost after unveiling plans to spin-off
its trucks business. It rose 8.9% while the broader index gained
0.3%.

Germany's DAX rose 0.7% to hit its highest in two
weeks.

London's blue-chip index slipped 0.1% as
GlaxoSmithKline slid 6.3% after it warned of a bigger
than expected fall in 2021 earnings as the COVID-19 pandemic
continues to disrupt other healthcare treatments.

But upbeat earnings from other companies helped push gains
on the pan-region index to a third straight day, with Novo
Nordisk, Siemens AG, Publicis Groupe SA
all rising after reporting results.

Drugmaker Argenx was the top gainer after it
raised $1 billion in capital increase.

Also keeping sentiment buoyed was hopes of U.S. stimulus
after the Senate took steps to allow Democrats to pass President
Joe Biden's proposed $1.9 trillion COVID-19 aid bill without
Republican support.

European stocks have been steadily rising along with other
major markets after losing more than 3% last week on concerns
around the slow roll-out of COVID-19 vaccines in the euro zone.

A pause in a social media driven rally that drove up prices
of silver as well as certain stocks including GameStop Corp
has helped calm worries about potential losses incurred
by certain hedge funds causing disruption to markets as a whole.
(Reporting by Shreyashi Sanyal in Bengaluru; Editing by Shounak
Dasgupta, Kirsten Donovan)

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.